INVIVO CELLULAR ADRIAMYCIN CONCENTRATIONS RELATED TO GROWTH-INHIBITION OF NORMAL AND LEUKEMIC HUMAN-BONE MARROW-CELLS

被引:26
作者
SPETH, PAJ [1 ]
RAIJMAKERS, RAP [1 ]
BOEZEMAN, JBM [1 ]
LINSSEN, PCM [1 ]
DEWITTE, TJM [1 ]
WESSELS, HMC [1 ]
HAANEN, C [1 ]
机构
[1] ST RADBOUD UNIV HOSP,DEPT HEMATOL,6500 HB NIJMEGEN,NETHERLANDS
来源
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY | 1988年 / 24卷 / 04期
关键词
D O I
10.1016/0277-5379(88)90297-0
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:667 / 674
页数:8
相关论文
共 23 条
[1]  
BUICK RN, 1979, J NATL CANCER I, V62, P249
[2]  
CARMO-PEREIRA J, 1986, Proceedings American Society of Clinical Oncology Annual Meeting, V5, P56
[3]   KINETICS AND SENSITIVITY OF DAUNORUBICIN IN PATIENTS WITH ACUTE-LEUKEMIA [J].
DEGREGORIO, MW ;
HOLLERAN, WM ;
MACHER, BA ;
LINKER, CA ;
WILBUR, JR .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1984, 13 (03) :230-234
[4]  
DEWITTE T, 1983, NETH J MED, V26, P67
[5]  
DEWITTE T, 1982, STEM CELLS, V2, P308
[6]   PHARMACOKINETIC STUDY OF IV-INFUSIONS OF ADRIAMYCIN [J].
EKSBORG, S ;
STRANDLER, HS ;
EDSMYR, F ;
NASLUND, I ;
TAHVANAINEN, P .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1985, 28 (02) :205-212
[7]  
GREENE RF, 1983, CANCER RES, V43, P3417
[8]  
HOLDRINET RSG, 1980, EXP HEMATOL, V8, P103
[9]   UPTAKE AND RETENTION OF ADRIAMYCIN AND DAUNORUBICIN BY SENSITIVE AND ANTHRACYCLINE-RESISTANT SUBLINES OF P388-LEUKEMIA [J].
INABA, M ;
JOHNSON, RK .
BIOCHEMICAL PHARMACOLOGY, 1978, 27 (17) :2123-2130
[10]   A PHASE I-II STUDY OF INTENSIVE-DOSE ADRIAMYCIN FOR ADVANCED BREAST-CANCER [J].
JONES, RB ;
HOLLAND, JF ;
BHARDWAJ, S ;
NORTON, L ;
WILFINGER, C ;
STRASHUN, A .
JOURNAL OF CLINICAL ONCOLOGY, 1987, 5 (02) :172-177